From Nasdaq:

Lemonade (LMND) stock closed at $16.05, with a -0.8% change from the previous day. Meanwhile, the S&P 500 rose by 1.07%, and the Dow increased by 0.35%. Nasdaq also saw a rise of 1.74%. Over the past month, Lemonade’s stock dropped by 2.59%, falling short of the Finance sector’s gain of 0.61% and the S&P 500’s gain of 2.93%.

Lemonade is projected to report earnings of -$0.79 per share, with a revenue of $113.1 million expected, marking a 27.94% increase from the year-ago quarter. The Zacks Rank system yields an average annual return of +25% since 1988, and Lemonade holds a Zacks Rank of #3 (Hold). Furthermore, the Insurance – Multi line industry currently has a Zacks Industry Rank of 111, putting it in the top 45% of all 250+ industries.

Finally, Zacks research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1 so investors should keep a close eye on Lemonade’s earnings. For more stock-influencing metrics and information, visit Zacks.com.

Zacks has identified a little-known chemical company that could double in value with unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares. Retail investors could see impressive gains from this investment. If you want the latest recommendations from Zacks Investment Research, you can download 7 Best Stocks for the Next 30 Days.



Read more: Lemonade (LMND) Stock Drops Despite Market Gains: Important Facts to Note